Vimarsana
Biggest News Aggregation in the World

Mellen Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mellen Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mellen Center Today - Breaking & Trending Today

Immunic to Participate in Investor and Scientific Conferences in May - Vimarsana News

Immunic to Participate in Investor and Scientific Conferences in May

NEW YORK, May 6, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

Immunic to Participate in Investor and Scientific Conferences in February - Vimarsana News

Immunic to Participate in Investor and Scientific Conferences in February

NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

Blood Test Could Predict Future Disability in MS - Vimarsana News

Blood Test Could Predict Future Disability in MS

Measuring levels of neurofilament light chain in the blood could warn of worsening disability up to 2 years before it occurs.

Immunic is developing a pipeline of oral therapies for chronic inflammatory and autoimmune diseases - Vimarsana News

Immunic is developing a pipeline of oral therapies for chronic inflammatory and autoimmune diseases

Deep Dive - Immunic Inc

Immunic Presents Data from Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS Meeting - Vimarsana News

Immunic Presents Data from Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS Meeting

NEW YORK - Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced that...